Dr Simpson is a Reader at the Wellcome-Wolfson Institute for Experimental Medicine and Academic Lead of the Genomics Core Technology Unit at Queen’s University Belfast. He has pioneered the application of genomic technologies within the University, particularly in vision science. His group were amongst the first to exploit next generation sequencing (NGS) techniques to screen panels of candidate genes for the inherited retinal disease Retinitis Pigmentosa (RP). He also uses NGS to profile circulating small RNAs as potential disease markers. More recently he has led development of single cell RNA-Sequencing locally and is applying this new technology to a range of pathologies, specifically to study how individual cells in the retina and vasculature are affected by diabetes. As a member of the COVID-19 Genomics UK (COG-UK) Consortium Dr Simpson is using nanopore and miniaturised Illumina library preparation protocols to sequence SARS-CoV-2 virus isolates. Dr Simpson obtained a BSc in Biological Sciences and PhD in Molecular microbiology at the University of Leicester, UK.